title: Steroid enzyme gene expressions during natural and androgen-induced gonadal differentiation in the rainbow trout, Oncorhynchus mykiss.
abstract: In fish, according to Yamamoto's model, androgens would drive testis differentiation and estrogens ovarian differentiation. In order to study the implication of steroid enzymes in rainbow trout gonadal differentiation, we examined the expression of some steroid enzyme genes during natural differentiation (cholesterol side chain cleavage = P450scc, 17-hydroxylase/lyase = P450c17, 3beta-hydroxysteroid dehydrogenase = 3betaHSD) and androgen-induced differentiation (P450scc, P450c17, 3betaHSD, aromatase = P450aro, and 11beta-hydroxylase = P45011beta). Expressions of P450scc, 3betaHSD, and P450c17 were all detected in male and female gonads at 55 days post-fertilization (dpf), i.e., two weeks before histological differentiation. There were no differences in their expression level respective to the sex. The androgen treatment was carried out by administration of 11beta-hydroxyandrostenedione (11betaOHDelta4) in genetic all-female populations and the resulting sex ratios were found to be 100% male even at a low dosage of 1 mg/kg of food. Following 11betaOHDelta4 treatment, only the expression of P450c17 was found to be sustained when compared with the female untreated control. In contrast, P450scc was clearly up-regulated and 3betaHSD and P450aro down-regulated by the androgen treatment. P45011beta gene expression remained low in gonads of androgen-treated females, as it did in control untreated females. These results together demonstrate that steroidogenesis in rainbow trout is potentially active in pre-differentiating gonads of both sexes, and that one of the masculinizing actions of androgens in the species may be to down-regulate the female-specific gonadal P450aro gene expression. However, in vivo androgen treatment in genetic females does not induce the same pattern of steroid gene expression as in genetic males. These data suggest that exogenous androgens might induce a male differentiation process with P450aro inhibition being one of the steps required. However, this process would not involve endogenously produced 11-oxygenated androgens.
authors.affiliation: INRA (Institut National de la Recherche Agronomique), Campus de Beaulieu, 35042 Rennes Cedex, France.
authors.forename: M
authors.initials: M
authors.lastname: Govoroun
authors.forename: O M
authors.initials: OM
authors.lastname: McMeel
authors.forename: H
authors.initials: H
authors.lastname: D'Cotta
authors.forename: M J
authors.initials: MJ
authors.lastname: Ricordel
authors.forename: T
authors.initials: T
authors.lastname: Smith
authors.forename: A
authors.initials: A
authors.lastname: Fostier
authors.forename: Y
authors.initials: Y
authors.lastname: Guiguen
mesh_terms: D000728:Androgens / Q000096:biosynthesis / Q000494:pharmacology*; D000818:Animals; D001141:Aromatase / Q000096:biosynthesis* / Q000378:metabolism; D002454:Cell Differentiation; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000096:biosynthesis* / Q000378:metabolism; D005260:Female; D018507:Gene Expression Regulation, Developmental; D006066:Gonads / Q000254:growth & development; D008297:Male; D017686:Oncorhynchus mykiss / Q000235:genetics* / Q000254:growth & development*
chemical_list: D000728:Androgens; D001141:Aromatase; D002786:Cholesterol Side-Chain Cleavage Enzyme